Associated Papers
Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance.
Vikova V et al.
Theranostics, 2019
30809292 (PubMed )
Supplement: thnov09p0540s1.pdf
Compendium of FAM46C gene mutations in plasma cell dyscrasias.
Barbieri M et al.
British Journal of Haematology, 2016
FAM46 proteins are novel eukaryotic non-canonical poly(A) polymerases.
Kuchta K et al.
Nucleic Acids Research, 2016
27060136 (PubMed )
Supplement: supp_gkw222_nar-00609-n-2016-File007.zip › TableS4.pdf
Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients.
Kortuem KM et al.
Blood Cancer Journal, 2016
26918361 (PubMed )
Supplement: bcj20161x1.pdf
Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.
Boyd KD et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2011
Select a paper to view details